Denali Therapeutics Inc (DNLI)
17.14
+0.33
(+1.96%)
USD |
NASDAQ |
May 03, 16:00
17.14
0.00 (0.00%)
Pre-Market: 20:00
Denali Therapeutics Total Return Level: 17.14 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 17.14 |
May 02, 2024 | 16.81 |
May 01, 2024 | 16.16 |
April 30, 2024 | 15.44 |
April 29, 2024 | 15.60 |
April 26, 2024 | 15.43 |
April 25, 2024 | 14.96 |
April 24, 2024 | 15.56 |
April 23, 2024 | 16.11 |
April 22, 2024 | 15.99 |
April 19, 2024 | 16.00 |
April 18, 2024 | 16.60 |
April 17, 2024 | 16.82 |
April 16, 2024 | 17.34 |
April 15, 2024 | 17.84 |
April 12, 2024 | 18.26 |
April 11, 2024 | 19.17 |
April 10, 2024 | 18.42 |
April 09, 2024 | 19.44 |
April 08, 2024 | 19.04 |
April 05, 2024 | 19.39 |
April 04, 2024 | 18.99 |
April 03, 2024 | 19.37 |
April 02, 2024 | 19.38 |
April 01, 2024 | 20.56 |
Date | Value |
---|---|
March 28, 2024 | 20.52 |
March 27, 2024 | 20.77 |
March 26, 2024 | 19.88 |
March 25, 2024 | 19.87 |
March 22, 2024 | 19.62 |
March 21, 2024 | 21.00 |
March 20, 2024 | 21.29 |
March 19, 2024 | 20.54 |
March 18, 2024 | 20.09 |
March 15, 2024 | 20.13 |
March 14, 2024 | 19.75 |
March 13, 2024 | 20.90 |
March 12, 2024 | 20.77 |
March 11, 2024 | 21.69 |
March 08, 2024 | 20.93 |
March 07, 2024 | 20.53 |
March 06, 2024 | 20.52 |
March 05, 2024 | 20.45 |
March 04, 2024 | 20.66 |
March 01, 2024 | 20.86 |
February 29, 2024 | 19.78 |
February 28, 2024 | 20.21 |
February 27, 2024 | 23.35 |
February 26, 2024 | 16.89 |
February 23, 2024 | 16.93 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
14.20
Minimum
Mar 16 2020
93.56
Maximum
Dec 22 2020
33.25
Average
27.96
Median
May 12 2023
Total Return Level Benchmarks
Halozyme Therapeutics Inc | 39.91 |
AIM ImmunoTech Inc | 0.4048 |
Perspective Therapeutics Inc | 1.81 |
Protalix BioTherapeutics Inc | 1.14 |
Armata Pharmaceuticals Inc | 2.49 |